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ABSTRACT OF DISSERTATION
DEPRESSION SCREENING BY UNIVERSITY COVID-19 CONTACT TRACERS
By
Lazara Medina
Florida International University, 2020
Miami, Florida
Professor Dr. Ellen Brown
The purpose of this DNP Project was to explore the feasibility of implementing a
depression screening protocol as a component of COVID-19 contact tracing procedures. Multiple
studies have established that in young adults, depression prevalence has increased during the
pandemic. A cross-sectional 18-item survey was developed and administered with a convenience
sample of contact tracers and administrators at a large public university. The transtheoretical
model (also known as the stages of change model) developed by Drs. Prochaska and Diclemente
(1992) guided the development of several survey items. Eleven people completed the web-based
survey. Participants reported depression was a significant problem among persons contacted
during contact tracing interviews. Several contact tracers “contemplated” the need to include
depression screening as part of the contact tracing interview but did not feel comfortable
screening and referring individuals with a positive screen. A number of steps were identified by
the survey respondents to “prepare” for mental health screening activities including staff
education, a mental health referral list, and a readily available evidence-based screening
measure. Further investigation will be needed to develop staff training and support for depression
screening procedures during contact tracing.
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Introduction
To date, more than 36 million people have been identified with coronavirus, and more
than 633,000 have died from the virus in the United States (Ritchie, 2021). Worldwide cases
increased to more than 204 million, which resulted in more than 4 million deaths (Ritchie, 2021).
COVID-19 has affected every part of life. Although the overall impact of COVID-19 on mental
health is unknown (Czeisler et al., 2020), it is generally agreed that social isolation due to stayat-home orders and physical distancing regulations have impacted overall emotional health and
well-being (Singhal, 2020). It is significant that a 2020 systematic review of 12 communitybased studies from January 1, 2020, to May 8, 2020, reported an overall depression prevalence of
25% during the coronavirus pandemic, indicating an increase prevalence compared to prepandemic estimates (Bueno-Notivol et al., 2021).
Background
The purpose of the following literature review was to define depression, examine what is
known about the prevalence of depression among persons with COVID-19 and specifically
among university students, describe commonly used depression screening measures and the role
of contact tracers.
Prevalence of Depression
Depression is a term that includes many depressive conditions, including minor
depression, major depressive disorder (MDD), and persistent depressive disorder (dysthymia)
(Bylsma & Panaite, 2013). Individuals suffering from depression experience a lack of interest,
sadness, decreased energy, sleep disturbances, changes in weight, feelings of loss, and
worthlessness. Approximately 75% of individuals suffering from untreated depression will
experience future episodes. The length of major depressive episodes varies, but the average
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duration is estimated to be 6 to 8 months (Bylsma & Panaite, 2013). Persons suffering from
depression are at risk for obesity, insomnia, substance or drug abuse, anxiety, social isolation,
suicidal ideation, and suicide.
Depression was a common health problem for university students before COVID-19
(Ibrahim et al., 2012). The prevalence of depression varies by the population, place of study,
socio-demographic factors, sampling, and diagnostic tool used (Weissman et al., 1996).
According to a systematic review, the prevalence of depression in university students from 1990
to 2010 fluctuated from 10% to 85% with a mean prevalence of 30.6% (Ibrahim et al., 2012).
These results indicate that students at universities experience higher rates of depression
compared to the rest of the population.
According to the findings of the United States National Health and Nutrition Examination
Survey (2018), from 2013 to 2016, 8.1% of Americans 20 years old or older were depressed for
2 weeks or more. Women were about twice as likely as men to be depressed. The prevalence of
depression decreased with high-income levels. The prevalence of depression was higher among
the Hispanics (8.2%), non-Hispanic Black (9.2%), and non-Hispanic White (7.9%) adults
compared to non-Hispanic Asian adults who had the lowest depression prevalence (3.1%)
(Brody et al., 2018).
Multiple studies (Ahmed et al., 2020; Bueno-Notivol et al., 2021;Ettman et al., 2020; Jia
et al., 2020) have established the prevalence of depression among positive COVID-19
individuals. Ettman et al. (2020) conducted a study to compare the prevalence of depression
before and during COVID-19 pandemic. The study involved 1441 participants during the
pandemic and 5065 participants from before the pandemic older than 18 years of age. In this
research, Ettman and his team used the nine-item Patient Health Questionnaire (PHQ-9) tool to
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assess depression. The researchers found that the prevalence rate of depression during
coronavirus pandemic increased more than threefold to 48.5 %. In addition, the study revealed
that individuals experiencing economic and social challenges were at the highest risk for
depression.
In their study, Jia et al. (2020) evaluated community members’ mental health residing in
United Kingdom during the COVID-19 pandemic. This survey involved 3097 participants older
than 18 years with a mean age of 44 years. The results from the study revealed that 64% of the
respondents reported symptoms of depression. Groups recognized being at higher risk for
depression were women, young adults, and individuals at higher risk for coronavirus disease.
The study conducted by Bueno-Notivol et al. (2021) also explored the prevalence of
depression in adults. These investigators conducted a systematic review of 12 community-based
studies from January 1, 2020, to May 8, 2020, that described the prevalence of depression during
COVID-19. The number of participants ranged from 600 to 7236, with a mean age from 32.2 to
49.1 years. All the studies used online questionnaires with standardized scales; the most common
was the PHQ-9. The results from the study revealed that the pooled prevalence of depression was
25%. The researchers concluded that compared to the global estimates of depression of 3.44% in
2017, the pooled prevalence of 25% was seven times higher than before the pandemic,
suggesting an important impact of coronavirus on the mental health of the general population.
The Ahmed et al. (2020) study assessed the mental health needs of 1074 Chinese
individuals aged from 14 to 68 years old during COVID-19 by conducting an online survey that
included the Beck Anxiety Inventory (Beck & Steer, 1993), the Beck Depression Inventory
(Beck et al., 1996), and the Alcohol Use Disorder Identification Test (Saunders et al., 1993).
Results from the study revealed higher prevalence for depression (37.1%) related to lockdown
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measures during coronavirus pandemic. Also, the population aged 21 to 40 years had higher
prevalence rates of anxiety, depression, and alcohol abuse than expected.
Several studies examined the prevalence of depression globally during previous epidemics
outbreaks, such as SARS and Ebola, the prevalence rates of depression in the overall population
fluctuated from 3% to 73.10% (Chew et al., 2020). However, previous pandemics were
controlled sooner, and infection rates were lower, which may explain the higher rates of
depression during COVID-19 (Huremović, 2019).
According to an online survey study in May 2020 of 4132 health responders living in
Kuwait aged 18 years old and older, responders younger than 30 years old were at the highest
risk of depression, and people with a high-school degree were more depressed than university
and postgraduate students (Burhamah et. al, 2020). A systematic review of 19 studies by Xiong
et al. (2020) found that the prevalence of depression ranged from 14.6% to 48.3% in the general
population during the COVID-19 pandemic in China, Spain, Italy, Iran, the U.S., Turkey, Nepal,
and Denmark. Several factors were found to increase depression, including being female or
being less than 40 years old, having a history of mental health or chronic illness, unemployment,
student status, use of social media, and prolonged time following the news regarding COVID-19
(Xiong et al., 2020). Overall, studies have reported very wide ranges for depression prevalence
during the pandemic, but there is agreement among them that the prevalence of depression was
lower before the pandemic. Additionally, women and younger populations were at highest risk.
Recommendations for Depression Screening
The U.S. Preventive Services Task Force (USPSTF) and the American Academy of
Family Physicians recommend screening for depression in the general adult population.
Depression screening is recommended for all adults older than 18 years. There is a shortage of
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evidence to recommend one screening instrument over another. The USPSTF found sufficient
evidence that programs linking screening for depression with support systems in place improves
clinical results in adults. The two-item and nine-item Patient Health Questionnaires (PHQs) are
the most commonly used depression screening tools (Siu et al., 2016). However, the PHQ-2
depression screening tool might be more appropriate for busy settings. The PHQ-2 inquiries
about the frequency of a depressed mood and anhedonia over the past 2 weeks, scoring each as 0
(“not at all”) to 3 (“nearly every day”). A PHQ-2 score of 3 or greater has a sensitivity of 83%
and a specificity of 92% for major depression disorder (Kroenke et al., 2003).
The PHQ-2 is recognized as an early screening tool in individuals older than 18 years. If
depression is detected, the PHQ-9 screening tool can then be completed to establish whether the
individual meets the criteria for depressive disorder (Siu et al., 2016). The PHQ-2 and PHQ-9
are openly accessible; no special permission is required to use, reproduce, or distribute the tools.
Also, these tools are free of charge and can be included in electronic medical records. The PHQ2 and PHQ-9 screening tools can be completed using smartphone applications and phone calls
(Pinto-Meza et al.,2005). Results from several studies have demonstrated that these methods
generate similar results to being administered in person. PHQ-2 and PHQ-9 are available in
multiple languages at www.phqscreeners.com (New York State Department of Health, 2016).
The 4-item Patient Health Questionnaire (PHQ-4) is a screening measure that consists of
a total of four items; two depression items (PHQ-2) and the two items generalized anxiety
disorder tool (GAD-2) (Löwe et al., 2010). The PHQ-4 tool serves as a general marker of mental
distress. The PHQ-4 screening may be useful as a brief screening tool for a very busy unit
concerned with screening cases of anxiety and depression. Individuals with a positive PHQ-4
screening result should be referred for further evaluation (Kroenke et al., 2009).
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Contact Tracers
In April 2020, the United States had approximately 11,142 contact tracers, which were
not enough to contain the outbreak of the pandemic (Simmons-Duffin, 2021). The country
needed to hire more than 100,000 contact tracers during the height of the pandemic. By the end
of December 2020, the contact tracing workforce increased from 11,000 to more than 70,000
(Simmons-Duffin, 2021). During the COVID-19 pandemic, contact tracing protocols have been
used to distinguish people who have been or probably were infected with COVID-19 and
quarantine them from others. Contacts are tracked by contact tracers and are asked to recall and
identify their contacts within 2 days before the onset of symptoms until they were quarantined
(CDC, 2020).
The CDC has trained contact tracers for more than 40 years. According to the CDC,
contact tracers need to complete disease-specific training. Additionally, contact tracer training
includes interview techniques, specific protocols (including the referral of individuals to
clinicians or support services), and privacy management (CDC, 2020). The CDC website
provides “COVID-19 Contact Tracing Guidance and Resources.”
Contact tracers are often but are not required to be healthcare professionals but need to
have cultural sensitivity, excellent interpersonal, and interviewing skills (CDC, 2020). They are
required to have skills such as how to counsel during a crisis and the capacity to refer individuals
if further care is needed (CDC, 2020). In the United States, contact tracers were required for
tuberculosis (TB), human immunodeficiency virus (HIV), and sexually transmitted infections
(STDs) (Armbruster & Brandeau, 2007). In addition, contact tracers have been used for
smallpox, severe acute respiratory syndrome (SARS), mouth and foot diseases, and avian
influenza (Armbruster & Brandeau, 2007).
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A usual day for a contact tracer includes making phone calls, collecting data, and
conducting interviews that would include collecting demographic and clinical information
including the individuals’ name, date of birth, home address, symptomatology, and the names of
people that the person has been in close contact with. Contact tracers work in a fast-paced
environment where time management skills are essential to precisely collect and document the
large amount of data.
In summary, due to the high prevalence rates of depression among university-aged adults
with COVID-19, exploration of the feasibility of integrating mental health screening during
contact tracing interviews is warranted.
Purpose
The purpose of this DNP Project was to explore the perspective of staff from a large
public university contact tracing unit on the feasibility of including depression screening during
routine COVID-19 contact tracing calls.
Research Questions
1. Is it feasible to include depression screening and make mental health referrals during
contact tracing interviews?
2. What are current barriers to implement depression screening during contact tracing?
3. What are some strategies to implement depression screening during contact tracing?
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Methodology
Study Design
The methodology used for this DNP project was a cross-sectional survey conducted with
a convenience sample. The protocol for this project was approved by the university Institutional
Review Board (IRB).
Setting
The setting for this DNP project was a large public university in the southeast. The
student population was nearly 54,000 (Florida International University, n.d.). The school serves a
diverse community of students, the majority of whom are Hispanic (61%), followed by White
non-Hispanic (15%), Black (13%), Asian or Pacific Islander (4%), and other minority groups
(7%) (Florida International University, n.d.).
Sample
All participants working on the COVID-19 response team or within the contact tracing
unit were eligible to participate.
Procedures
Emails with the study flyer were sent to all potential participants by the unit
administrator. The study flyer included a direct link to the study informational letter and survey.
Once individuals completed the 18-item survey, investigators had access to the answers provided
in Qualtrics. Investigators were not able to identify the identity of individuals.
Survey
An 18-item survey was developed to address the research questions. The survey consisted
of four parts: demographics, perceptions about implementing mental health screening during
contact tracing interviews, mental health screening tools, and potential barriers to screening and
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referral. Demographic items included the participants’ role at the university, professional license,
and contact tracer experience. Participants were asked about their comfort in administering and
scoring the PHQ-4. The PHQ-4 was provided for review because it was unknown if participants
were familiar with this screening instrument. Although, this DNP Project was focused only on
depression, another DNP Project was focused on anxiety and anxiety screening. Therefore,
several survey items seek to gain insight on overall mental health screening.
A conceptual model, the transtheoretical model (TTM) (Prochaska & DiClemente, 1992),
was used to guide the development of the survey. TTM, or the stages of change model, involves
the progression through multiple stages. TTM is based on research done on addictive behaviors
and the assumption that people do not change behaviors abruptly. Rather, people change
behaviors through a cyclical process moving through multiple stages of change: precontemplation (no intention to change behavior or unaware of a problem), contemplation (aware
that the problem exists and thinking about change but not committed to it), preparation
(intending to act soon), action (modification of behavior), maintenance (prevention of relapse
and consolidation of gains), and relapse (Prochaska & DiClemente, 1992).
Consistent with the research conducted by Brown et al. (2004) focused on readiness of
home healthcare nurses to conduct depression screening, a goal was to categorize participants
into one of three stages regarding depression screening. Since depression screening was not
being conducted, the application of the pre-contemplation, contemplation, and preparation stages
was most relevant. According to TTM, in the pre-contemplation stage, individuals have not
considered that there is a reason to change. The survey included several questions to determine if
the participants believed there was a problem or a reason to add depression screening to their
routine procedures. The survey items included: Do you think that mental health issues are a
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problem among positive COVID-19 individuals in the community? What percentage of the
individuals with COVID-19 interviewed do you think are depressed? If individuals did not
consider that there was a significant problem with depression or mental health, they were
categorized as “pre-contemplators.”
It is at the stage of “contemplation” (Prochaska & DiClemente, 1992) that the individual
becomes aware of the existence of a problem. This stage is where the individuals recognize the
advantages and disadvantages of change and feel torn about making a change. The survey
included the following items focused on “contemplating” change: Have you ever thought about
implementing depression screening in the context of contact tracing? What barriers would be
encountered implementing depression screening during contact tracing interview? If individuals
did consider that there was a significant problem with depression or mental health and had
thought about implementing depression/anxiety screening in the context of contact tracing, they
would be categorized as “contemplators.”
In the preparation stage, individuals have made a commitment to change behavior and
accept the responsibility for doing so (Prochaska & DiClemente, 1992). The survey included the
following items focused on the “preparation” stage: After reviewing the PHQ-4, how
comfortable are you performing screening for depression? If there is a positive screen for
depression, are you prepared to make referrals for mental health services? If the individuals were
comfortable performing screening for depression, and if they were prepared to make referrals for
mental health services, they would be categorized as “persons preparing to take action.”
Data Management and Analysis
The data was collected, stored, and analyzed using the Qualtrics server (password
protected). The data analysis included the use of descriptive statistics to describe the
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individuals’ survey items. To examine the feasibility of including depression screening during
contact tracing interviews, participants were classified into three groups based on the TTM (i.e.,
pre-contemplators,” “contemplators,” and “persons preparing to take action”) as previously
described.
Results
Eleven participants responded to the survey. Of the 11, five self-identified as contact
tracers and one as an administrator (five people did not respond). Of the five contact tracers,
three had previous experience (5 years; 4 years; 10 months), and two did not have previous
experience as contact tracers.
Mental Health Significance and Screening
Four participants responded to the item inquiring about the significance of mental health
issues among positive COVID-19 individuals at the university. One participant responded that
the significance was 5, another responded 6, and two participants responded 7 on a scale from 0
to 10 where 0 = non-significant and 10 = very significant.
Four participants responded to the item inquiring about the percentage of individuals that
participants thought were depressed during contact tracing interviews. Their responses were
10%, 25%, 45%, and 60% depression prevalence.
Three participants had considered conducting depression screening as part of the contact
tracing interview, and two had not considered conducting depression screening as part of the
contact tracing interview (six people did not respond to the item).
Current Barriers
Five participants identified multiple barriers to conduct depression screening during
contact tracing interviews, including lack of cooperation by participants, lack of time, and lack of
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training (six participants did not answer the item). Four participants reported that it is feasible to
include the PHQ-4 screening tool during the interviews (seven did not answer). Two of the
responders reported that “contact tracers are not prepared to refer a patient with a positive
screening;” two answered that “contact tracers are prepared to refer individuals with positive
screening;” and seven did not answer.
The two participants indicating contact tracers are not prepared to refer individuals with a
positive PHQ-4 reported that making mental health referrals would require a list of campus
mental-health services, local health services, web-based services, educational materials, and
additional training. Participants were asked to indicate all of the reasons why mental health
screening was not being conducted. Five participants thought mental health screening during
contact tracing interviews has not been done for multiple reasons including “no screening tools
available on current tracing form”; “not sure what to do with a positive screen;” “not familiar
with the resources at the university and local resources;” “not enough time;” “inconsistency with
the overall goal of contact tracing, and lack of support from leadership.”
Four participants agreed with conducting mental health screening during contact tracing
interviews but thought training was necessary to implement screening procedures. Specifically,
participants reported that adding screening tools to the current electronic-based system,
education on how to score the tool, and more time was needed to conduct depression screening
(seven people did not answer this survey item).
Discussion
Consistent with the literature (Ahmed et al., 2020; Bueno-Notivol et al., 2021; Ettman et
al., 2020; Jia et al., 2020), most respondents viewed depression as a significant problem among
persons contacted during contact tracing interviews. The prevalence estimates reported by the
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participants was overall around 35%, further indicating they were aware of the problem.
Interestingly, this high prevalence rate is consistent with the high rates found in the literature
(Ahmed et al., 2020; Bueno-Notivol et al., 2021; Ettman et al., 2020; Jia et al., 2020).
A number of survey items focused on the feasibility of conducting depression screening
as part of the contact tracing procedures. Most of the respondents “contemplated” the need to
conduct depression screening and believed depression screening during contact tracing
interviews was feasible. However, respondents reported many barriers to implement this change.
These individuals did not feel prepared to refer people with a positive screen to a clinician. Some
of the barriers reported include lack of cooperation by participants, lack of time, and lack of
training. Additionally, survey respondents reported that they would require information about
campus mental-health services, local health services, web-based services, and educational
materials. Consequently, it is not surprising that contact tracers are not confident to identify and
refer individuals suffering with depression. The implications of these findings support the need
for mental health support services information, additional training, and educational materials that
target both contact tracers and administrators at the contact tracing unit.
Use of depression screening tools alone will not address the problem of depression during
the COVID-19 pandemic. Contact tracers would need to refer people with a positive depression
screen to clinicians for further evaluation by a primary care provider or mental health
professional. Further efforts must target how to transfer the information collected during contact
tracing interviews to primary care providers or mental health clinicians.
Limitation of the Study
This small survey study had many limitations. First, several participants did not answer
all the survey items. Therefore, conclusions regarding these data should be interpreted with
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caution. Second, the changing pandemic case count may impact survey responses. For example,
the feasibility of conducting mental health screening may not seem feasible when the contact
tracers are very busy. Finally, the contact tracers interviewed have differing professional
backgrounds, and it is unknown if these differences impact survey responses.
Conclusion
These results indicate that it would be feasible to conduct depression screening as a
component of a contact tracing interview with training and organizational support. Several
contact tracers “contemplated” the need to conduct depression screening as part of the contact
tracing interview but did not feel comfortable identifying and referring individuals suffering with
depression (Prochaska, 2000). To move toward the “preparation” stage, additional educational
programs, support services, and tools are needed to address this significant community health
problem. Further, an analysis and evaluation of current contact tracing training programs about
mental health problems, including depression, is warranted.
Implications for Advanced Practice Nurses (APNs)
Including depression screening during COVID-19 contact tracing interviews may help in
early recognition of individuals suffering from depression. APNs play an important role in the
screening, diagnosing, and treating individuals with depression. Barriers for depression
recognition include stigma related to mental health conditions, denial, clinician’s knowledge,
limited time, and others. Depression screening during contact tracing and proper and timely
referrals is feasible with support and proper training. Contact tracers and administrators will
need education to address this problem. APRNs are optimally positioned to provide education
and training about coronavirus disease, conduct depression screening, and make appropriate
depression referrals.
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